Colors: Green Color

With 2019 drawing to a close and the new year upon us, it’s very typical to start making New Year's resolutions such as eating healthier, reducing procrastination, or spending less. Most resolutions include learning something new or trying to do something better.

Eisai Co., Ltd. has announced that LENVIMA (generic name: lenvatinib), the orally available kinase inhibitor discovered by Eisai, has been accepted by the National Medical Products Administration of China for an application for the additional indication of differentiated thyroid cancer. This application for additional indication marks the second in China following the indication for hepatocellular carcinoma, which was approved in September 2018.